Best disease: Definition, Uses, and Clinical Overview

Best disease Introduction (What it is)

Best disease is an inherited eye condition that affects the macula, the central part of the retina used for detailed vision.
It is also called Best vitelliform macular dystrophy (BVMD).
It is most commonly discussed in retina clinics and genetic eye disease evaluations.
People often learn about it after an eye exam shows a characteristic “yellow” macular lesion or unexplained central vision changes.

Why Best disease used (Purpose / benefits)

Best disease is not a treatment or device; it is a diagnosis. In clinical practice, “using” Best disease typically means recognizing, confirming, and monitoring the condition so that vision changes are interpreted correctly and complications are detected early.

The main purpose of identifying Best disease is to explain a pattern of macular changes and central-vision symptoms that can look like other retinal conditions. Best disease can cause blurred or distorted central vision (metamorphopsia), reduced sharpness for reading, and sometimes changes in color perception. However, many people have relatively good vision for long periods, and the appearance of the macula can change over time.

A clear diagnosis can also be useful for:

• Choosing appropriate testing (for example, retinal imaging and electrophysiology) to document disease stage and progression.
• Distinguishing Best disease from more common causes of macular findings, such as age-related macular degeneration (AMD) or central serous chorioretinopathy.
• Guiding monitoring for complications, especially choroidal neovascularization (CNV), which is abnormal blood vessel growth under the retina.
• Genetic counseling discussions, because Best disease is often inherited (commonly autosomal dominant), though patterns can vary by family and genetic variant.
• Setting realistic expectations about what symptoms might occur and what vision functions may remain stable.

Indications (When ophthalmologists or optometrists use it)

Best disease is typically considered when a clinician sees certain macular findings or when symptoms and family history raise suspicion. Common scenarios include:

• A yellow, “egg-yolk–like” lesion in the macula (a vitelliform lesion) on dilated exam
• Unexplained central blur, distortion, or a small central blind spot (scotoma)
• Reduced vision that does not match the degree of refractive error (glasses prescription)
• Macular changes in a child, teenager, or young adult (though age at detection can vary)
• A family history of “macular dystrophy,” inherited retinal disease, or similar findings
• Abnormal retinal imaging suggestive of vitelliform material (on OCT or fundus autofluorescence)
• Evaluation of suspected CNV in someone known or suspected to have Best disease

Contraindications / when it’s NOT ideal

Because Best disease is a diagnosis rather than a procedure, “contraindications” are best understood as situations where Best disease is less likely or where other conditions may be a better fit and should be evaluated.

Best disease may be less favored as an explanation when:

• The macular findings are more consistent with AMD in an older adult (though overlap in appearance can occur)
• A vitelliform-appearing lesion is better explained by adult-onset vitelliform macular dystrophy, pattern dystrophy, or medication-related retinal changes (classification can vary by clinician and case)
• Symptoms and imaging fit central serous chorioretinopathy (subretinal fluid patterns and risk factors may differ)
• Findings suggest Stargardt disease or other inherited retinal disorders with different imaging signatures
• There is significant ocular comorbidity (e.g., advanced cataract, corneal disease) that limits the quality of retinal examination and imaging, requiring staged evaluation
• The overall clinical picture suggests an inflammatory, infectious, vascular, or toxic cause that needs a different workup

How it works (Mechanism / physiology)

Best disease is primarily a disorder of the retinal pigment epithelium (RPE), a layer of cells that supports the photoreceptors (the retina’s light-sensing cells). Many cases are associated with variants in the BEST1 gene, which affects a protein (bestrophin-1) involved in RPE function. The exact downstream effects can vary depending on the genetic change.

At a high level:

• The macula accumulates lipofuscin-like material and other debris in and under the retina, forming the classic vitelliform (“egg-yolk”) appearance.
• Over time, the vitelliform material can break up and shift, and some people develop thinning or atrophy of retinal layers that are important for fine vision.
• The condition involves the macula most prominently, which is why symptoms typically affect reading, recognizing faces, and other detailed tasks, while side vision may remain less affected.

A notable feature is that Best disease can show an abnormal result on an electro-oculogram (EOG), a test that assesses RPE-related electrical responses. The EOG finding is often described as a reduced Arden ratio. Not every clinic uses EOG routinely, and test selection varies by clinician and case.

Onset, duration, and reversibility:

• Best disease is usually long-term and not reversible in the sense of restoring the macula to a pre-disease state.
• The rate of change is variable, and some people maintain functional central vision for extended periods.
• Symptoms may fluctuate when fluid or CNV develops, which is one reason monitoring can be important.

Best disease Procedure overview (How it’s applied)

Best disease is applied clinically through diagnosis, staging, and monitoring, rather than a single intervention. A typical workflow may include:

1. Evaluation / exam – Symptom review (blur, distortion, reading difficulty) – Family history and age at onset – Visual acuity testing and dilated retinal exam

2. Preparation – Baseline measurements and imaging planning (often in the same visit) – Discussion of which tests are needed and why (varies by clinician and case)

3. Intervention / testing – Optical coherence tomography (OCT): cross-sectional retinal imaging to look for vitelliform material, subretinal fluid, and layer integrity – Fundus autofluorescence (FAF): helps highlight lipofuscin-related signals and lesion patterns – Color fundus photography: documents appearance over time – OCT angiography (OCT-A) or fluorescein angiography (FA): may be used when CNV is suspected – Electrophysiology (EOG and sometimes ERG): may support diagnosis in selected cases – Genetic testing: may be considered to confirm a BEST1-related diagnosis and clarify inheritance (use varies by region and clinic)

4. Immediate checks – Review of imaging results and whether additional tests are needed – Baseline comparison plan for future visits

5. Follow-up – Periodic monitoring of vision and macular imaging – Additional evaluation if symptoms change or imaging suggests complications such as CNV

Types / variations

Best disease is often discussed alongside closely related “vitelliform” and BEST1-associated conditions. Terminology and categorization can vary by clinician and case, but common variations include:

• Best vitelliform macular dystrophy (classic Best disease / BVMD): typically associated with BEST1 variants and a characteristic macular vitelliform lesion.
• Stage-based descriptions (clinical evolution):
• Vitelliform stage: classic yellow lesion
• Pseudohypopyon stage: layering of material may be seen
• Vitelliruptive stage (“scrambled egg”): breakup of the lesion
• Atrophic stage: retinal thinning/atrophy may develop
• Some clinicians also describe a pre-vitelliform stage with subtler findings
• Adult-onset vitelliform macular dystrophy (AOVMD): a related clinical pattern that can resemble Best disease but often differs in genetics, typical age, and testing patterns.
• Bestrophinopathies (BEST1 spectrum): BEST1 variants can be associated with other retinal phenotypes beyond classic BVMD. Whether a given case is labeled “Best disease” or another entity depends on the clinical findings and testing.

Pros and cons

Pros:

• Provides a coherent explanation for a characteristic macular appearance and central-vision symptoms
• Helps differentiate inherited dystrophy from acquired macular disease in many cases
• Supports structured monitoring using OCT/FAF and vision testing
• Can improve detection of complications such as CNV that may require targeted management
• May inform family risk discussions and genetic evaluation pathways
• Encourages realistic expectations about variability in the course of macular change

Cons:

• Clinical course is variable, making prognosis difficult to generalize
• There is no single definitive “cure” that restores normal macular anatomy in established disease
• Testing can be time-consuming or access-limited (e.g., EOG or genetics availability varies)
• The diagnosis can create psychological stress related to uncertainty and inheritance
• Some cases are hard to classify, especially when vitelliform changes overlap with other disorders
• Visual function may be affected even when the eye looks relatively stable, and vice versa

Aftercare & longevity

Long-term outcomes in Best disease depend on multiple factors, and the pattern is not identical for everyone. Longevity of functional vision is influenced by:

• Disease stage and lesion behavior (whether vitelliform material remains stable, breaks up, or progresses toward atrophy)
• Presence or absence of complications, particularly CNV or persistent subretinal fluid
• Baseline retinal structure, including how well key layers (such as the photoreceptor-associated bands on OCT) are preserved
• Follow-up consistency, which affects how quickly new changes are detected
• Other eye conditions (for example, cataract, glaucoma, diabetic eye disease) that can reduce vision independently
• Testing and imaging quality, which can be impacted by dry eye, small pupils, media opacity, or fixation difficulty
• Device and method differences in imaging systems and interpretation (varies by material and manufacturer; also varies by clinic protocols)

In general informational terms, aftercare usually means periodic eye examinations and imaging, with additional assessment if new distortion, a sudden drop in vision, or new central blind spots occur.

Alternatives / comparisons

Best disease is often considered in a differential diagnosis—meaning it is compared with other causes of similar symptoms or macular appearance.

Common comparisons include:

• Observation/monitoring vs active intervention:
  Many people with Best disease are monitored over time, while intervention may be considered if complications like CNV develop. The threshold to escalate evaluation or treatment varies by clinician and case.

• Best disease vs age-related macular degeneration (AMD):
  Both can involve central vision and abnormal material under/within the retina, but AMD is typically age-associated and has different risk factors and imaging patterns. Best disease is typically inherited and often presents earlier, though detection age varies.

• Best disease vs Stargardt disease:
  Both are inherited and affect the macula, but Stargardt disease often shows distinct flecks and characteristic autofluorescence patterns, and the genetics are different.

• Best disease vs central serous chorioretinopathy (CSC):
  CSC often features subretinal fluid with a different underlying mechanism and clinical context. Vitelliform material and EOG/genetic patterns can help separate entities.

• Best disease vs adult-onset vitelliform macular dystrophy / pattern dystrophy:
  These can look similar on exam. Age at presentation, family history, imaging features, and (when used) electrophysiology/genetics help refine classification.

Best disease Common questions (FAQ)

Q: Is Best disease the same as “having the best vision”?
No. Best disease is named after the physician who described it, not because it improves vision. It refers to an inherited macular dystrophy that can affect central vision.

Q: Does Best disease cause pain or eye redness?
Best disease typically does not cause eye pain or redness by itself. Symptoms are usually visual (blur, distortion, difficulty with fine detail). If pain or redness occurs, clinicians usually consider other causes as well.

Q: How is Best disease diagnosed?
Diagnosis usually relies on a combination of the dilated retinal exam and imaging such as OCT and fundus autofluorescence. Some cases also use EOG testing to assess RPE-related function, and genetic testing may be considered to confirm a BEST1-associated diagnosis. The exact workup varies by clinician and case.

Q: Can Best disease affect one eye more than the other?
Yes. Best disease often involves both eyes, but severity and timing can differ between eyes. Asymmetry is not unusual, especially early on or during periods of change.

Q: How long do the effects of Best disease last?
Best disease is generally a long-term condition. The appearance of the macula and the level of central vision can change over years, and the pace is variable. Some people remain stable for extended periods, while others progress more noticeably.

Q: Is Best disease considered “safe” or “dangerous”?
Best disease is not a procedure, so “safety” is not the usual framing. The main concern is how much central vision function is affected and whether complications like CNV develop. Risk and impact vary by clinician and case.

Q: What treatments are available for Best disease?
There is no single universally applicable treatment that reverses the underlying dystrophy. Management is often focused on monitoring and addressing complications if they occur, such as CNV, which may be treated with medications delivered by eye injection in many retinal conditions. Whether treatment is used depends on the specific findings.

Q: Will I still be able to drive or use screens with Best disease?
This depends on visual acuity, contrast sensitivity, distortion, and local driving vision requirements. Many people can use screens, sometimes with adjustments (font size, contrast), but individual experience varies. Clinicians typically assess functional vision over time rather than making assumptions from diagnosis alone.

Q: Is Best disease inherited, and should family members be checked?
Best disease is often inherited, commonly in an autosomal dominant pattern, though genetics can vary. Because families differ, clinicians may discuss eye exams for relatives and the role of genetic testing on a case-by-case basis. Decisions about family evaluation are individualized.

Q: How much does evaluation and monitoring cost?
Costs vary widely by country, insurance coverage, clinic setting, and which tests are used (imaging, electrophysiology, genetics). Some tests are commonly available in routine eye care, while others may require specialty referral. The overall cost range cannot be generalized without local context.